Publicaciones en colaboración con investigadores/as de Cincinnati Children's Hospital Medical Center (13)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

2022

  1. Src kinase as a potential therapeutic target in non-alcoholic and alcoholic steatohepatitis

    Clinical and Translational Discovery, Vol. 2, Núm. 1

2020

  1. Vaginal metabolome: towards a minimally invasive diagnosis of microbial invasion of the amniotic cavity in women with preterm labor

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice

    Blood Advances, Vol. 2, Núm. 19, pp. 2491-2504

2017

  1. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

    Open Heart, Vol. 4, Núm. 2

  2. The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia

    Leukemia

2015

  1. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

    Leukemia, Vol. 29, Núm. 7, pp. 1458-1469

  2. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

    Nature Medicine, Vol. 21, Núm. 6, pp. 555-559

2012

  1. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs

    Leukemia, Vol. 26, Núm. 6, pp. 1329-1337

  2. Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival

    Blood, Vol. 120, Núm. 4, pp. 800-811

2009

  1. Prognostic factors and outcomes for osteosarcoma: An international collaboration

    European Journal of Cancer, Vol. 45, Núm. 13, pp. 2367-2375